These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24516881)
21. Recent developments in health law. India's evolving patent laws and WTO obligations: the rejection of Abbott Laboratories' application for a new Kaletra patent. Chilton A J Law Med Ethics; 2011; 39(2):296-300. PubMed ID: 21710799 [No Abstract] [Full Text] [Related]
22. Novartis challenges India's drug patent laws in Supreme Court. Billingsley M BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594 [No Abstract] [Full Text] [Related]
23. Intellectual property. Balancing innovation and access: patent challenges tip the scales. Higgins MJ; Graham SJ Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944 [No Abstract] [Full Text] [Related]
27. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984. Lewis RA J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987 [No Abstract] [Full Text] [Related]
28. Old drugs, new uses: solving a Hatch-Waxman patent predicament. McPhie DC Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929 [No Abstract] [Full Text] [Related]
30. High Court strikes down Merck's patent on alendronate. Dyer O BMJ; 2003 Feb; 326(7383):243. PubMed ID: 12560269 [No Abstract] [Full Text] [Related]
31. The transatlantic divide: how divisional and continuing patent application filing practice differs between the USA and Europe. Nytko-Lutz E; Crease D Pharm Pat Anal; 2012 Jul; 1(3):245-8. PubMed ID: 24236836 [TBL] [Abstract][Full Text] [Related]
32. Patent owner options for correcting errors in US patents after grant. Armstrong M Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319 [TBL] [Abstract][Full Text] [Related]
33. Patent watch. Harrison C Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746 [No Abstract] [Full Text] [Related]
34. Korea: the new first battleground for the high stakes poker game of pharmaceutical patent litigation. Choe JY; Yoon KA; Lee S Pharm Pat Anal; 2015; 4(6):409-13. PubMed ID: 26580988 [No Abstract] [Full Text] [Related]
35. The application of the patent laws to the drug approval process. Coggio BD; Cerrito FD Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669 [No Abstract] [Full Text] [Related]
36. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
37. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives. Altman D; Sweeney C; Yasui T Pharm Pat Anal; 2014 Sep; 3(5):469-73. PubMed ID: 25374314 [No Abstract] [Full Text] [Related]
38. Anxious wait for patients and big pharma. Kirby T Lancet Neurol; 2015 Mar; 14(3):246-7. PubMed ID: 25728435 [No Abstract] [Full Text] [Related]
39. Generics still unable to resolve ANDA patent issues by declaratory judgment, but is a supreme court resolution on the way? Eccleston LE Health Care Law Mon; 2006 Dec; ():3-5. PubMed ID: 17236678 [No Abstract] [Full Text] [Related]
40. Patents: a threat to innovation? Manocaran M Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]